Molecular characterisation of newly identified HIV-1 infections in Curitiba, Brazil: Preponderance of clade C among males with recent infections

Memorias do Instituto Oswaldo Cruz

Volumn 103, Issue 8, 2008, Pages 800-808

  De Paula Ferreira, João Leandro ^a   Thomaz, Mariana ^b   Rodrigues, Rosangela ^a   Harrad, David ^b   Oliveira, Cristina Mendes ^a   De Freitas Oliveira, Carmem Aparecida ^a   Batista, João Paulo Gervasio ^a   Ito, Tomoko Sezazake ^c   De Macedo Brigido, Luis Fernando ^d  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b Coordenação Municipal de DST/Aids de Curitiba ^*  (Brazil)

^c Laboratório Central do Município de Curitiba   (Brazil)

^d Research Capacity Program   (Brazil)

Author keywords

Antiretroviral resistance; Brazil; Epidemiology; Genetic diversity; Hiv 1 tropism

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 58049176428     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/s0074-02762008000800010     Document Type: Article

References (48)

1. Baeten JM, Chohan B, Lavreys L, Chohan V, McClelland RS, Certain L, Mandaliya K, Jaoko W, Overbaugh J 2007. HIV-1 subtype D infection is associated with faster disease progression than sub-type A in spite of similar plasma HIV-1 loads. J Infect Dis 195: 1177-1180.
2. Barreto CC, Nishyia A, Araújo LV, Ferreira JE, Busch MP, Sabino EC 2006. Trends in antiretroviral drug resistance and clade distributions among HIV-1-infected blood donors in São Paulo, Brazil, J Acquir Immune Defic Syndr 41: 338-341.
3. Bon I, Gibellini D, Borderi M, Alessandrini F, Vitone F, Schiavone P, Maria Carla Re 2007. Genotypic resistance in plasma and peripheral blood lymphocytes in a group of naive HIV-1 patients. J Clin Virol 38: 313-320.
4. Bongertz V, Bou-Habib DC, Brigido LF, Caseiro M, Chequer PJ, Couto-Fernandez JC, Ferreira PC, Galvão-Castro B, Greco D, Guimarães ML, Linhares de Carvalho MI, Morgado MG, Oliveira CA, Osmanov S, Ramos CA, Rossini M, Sabino E, Tanuri A, Ueda M 2000. HIV-1 diversity in Brazil: genetic, biologic and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites. J Acquir Immune Defic Syndr 23:184-193.
5. Brigido LF, Franco HM, Custodio RM, Oliveira CA, P Ferreira JL, Eira M, Bergel F, Araújo F, Carvalheiro JR, Rodrigues R 2005. Molecular characteristics of HIV type 1 circulating in São Paulo, Brazil, AIDS Res Hum Retroviruses 21: 673-682.
6. Brigido LF, Nunes CC, Oliveira CM, Knoll R, Ferreira JLP, Oliveira CAF, Alves MA, Dias CF, Rodrigues R, Research Capacity Program 2007. HIV-1 Subtype C and Cb Pol Recombinants prevail at the cities with the highest Aids prevalence rate of Brazil. AIDS Res Hum Retroviruses 23: 1579-1585.
7. Brindeiro RM, Diaz RS, Sabino EC, Morgado MG, Pires IL, Brigido L, Dantas MC, Barreira D, Teixeira PR, Tanuri A 2003. Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals. AIDS 17: 1063-1069.
8. Cerqueira DM, Amorim RM, Silva RR, Camara GN, Brigido MM, Martins CR 2004. Antiretroviral resistance and genetic diversity of human immunodeficiency virus type 1 isolates from the Federal District, Central Brazil. Mem Inst Oswaldo Cruz 99: 877-882.
9. Cong M, Heneine W, J Gerardo García-Lerma 2007. The fitness cost of mutations associated with human immunodeficiency virus type 1 drug resistance is modulated by mutational interactions. J Virol 6: 3037-3041.
10. De Medeiros LB, Lacerda HR, Cavalcanti AM, de Albuquerque MF 2006. Primary resistance of human immunodeficiency virus type 1 in a reference center in Recife, Pernambuco, Brazil. Mem Inst Oswaldo Cruz 101: 845-849.
11. Eyer-Silva WA, Couto-Fernandez JC, Silva-de-Jesus C, Morgado MG 2008. Prevalence of HIV type 1 drug resistance mutations in treatment-naïve and experienced patients from resource-limited settings with universal access to antiretroviral therapy: a survey in two small Brazilian cities. Mem Inst Oswaldo Cruz 103: 143-149.
12. Gadelha SR, Shindo N, Cruz JN, Morgado MG, Galvão-Castro B 2003. Molecular epidemiology of human immunodeficiency virus-1 in the state of Ceara, Northeast Brazil. Mem Inst Oswaldo Cruz 98: 461-463.
13. Grant RM, Hecht FM, Warmerdam M, Liu L, Liegler T, Petropoulos CJ, Hellmann NS, Chesney M, Busch MP, Kahn JO 2002. Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA 288: 181-188.
14. Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, Karon J, Brookmeyer R, Kaplan EH, McKenna MT, Janssen RS, Merriweather A, Mergenthaler H, Donnelly JA, Noga H, White S, Crippen D, Merritt M, Benbow N, Fields DK, Ramirez S, O'Connor M, Van Dyne M, Singh S, Cross H, Smith L, Bennani Y, Padgett PJ, Harris T, Obiri G, Brady KA, McCormick K, Shavor TJ, Jablonski CL, Chan S, Diallo N, Exarchos A, DeCausey B, Bodnar U, Glynn MK, Green T, Hernandez A, Kline R, Lin LS, Linley L, Walker F, Wheeler W, HIV Incidence Surveillance Group 2008. Estimation of HIV incidence in the United States. JAMA 6; 300: 520-529.
15. Hemelaar J, Gouws E, Ghys PD, Osmanov S 2006. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 20: W13-23.
16. John-Stewart GC, Nduati RW, Rousseau CM, Mbori-Ngacha DA, Richardson BA, Rainwater S, Panteleeff DD, Overbaugh J 2005. Subtype C is associated with increased vaginal shedding of HIV-1. J Infect Dis 192: 492-496.
17. Kaleebu P, Nankya IL, Yirrell DL, Shafer LA, Kyosiimire-Lugemwa J, Lule DB, Morgan D, Beddows S, Weber J, Whitworth JA 2007. Relation between chemokine receptor use, disease stage and HIV-1 subtypes A and D: results from a rural Ugandan cohort. J Acquir Immune Defic Syndr 1: 45: 28-33.
18. Koch WH, Sullivan PS, Roberts C, Francis K, Downing R, Mastro TD, Nkengasong J, Hu D, Masciotra S, Schable C, Lal RB 2001, Evaluation of United States-licensed human immunodeficiency virus immunoassays for detection of group M. viral variants. J Clin Microbiol 39: 1017-1020.
19. Martinez AMB, Barbosa EF, Ferreira PCP, Cardoso FA, Silveira J, Sassi G, da Silva CM, Mendonça-Signorini V, Antunes CM 2002. Molecular epidemiology of HIV-1 in Rio Grande, RS, Brazil. Rev Soc Bras Med Trop 35: 471-476.
20. Montano SM, Sanchez JL, Laguna-Torres A, Cuchi P, Avila MM, Weissenbacher M, Serra M, Viñoles J, Russi JC, Aguayo N, Galeano AH, Gianella A, Andrade R, Arredondo A, Ramirez E, Acosta ME, Alava A, Montoya O, Guevara A, Manrique H, Sanchez JL, Lama JR, de la Hoz F, Sanchez GI, Ayala C, Pacheco ME, Carrion G, Chauca G, Perez JJ, Negrete M, Russell KL, Bautista CT, Olson JG, Watts DM, Birx DL, Carr JK, the South American HIV Molecular Surveillance Working Group 2005. Prevalences, genotypes and risk factors for HIV transmission in South America. J Acquir Immune Defic Syndr 40: 57-64.
21. Oliveira CAF, Ueda M, Yamashiro R, Rodrigues R, Sheppard HW, de Macedo Brigido LF 2005. Rate and incidence estimates of recent human immunodeficiency virus type 1 infections among pregnant women in São Paulo, Brazil, from 1991 to 2002. J Clin Microbiol 43: 1439-1442.
22. Pedroso C, Queiroz ATL, Alcântara L, Drexler JF, Diaz RS, Wey N, Brites C 2007. High prevalence primary antiretroviral resistance among HIV-1-infected adults and children in Bahia, a northeast state of Brazil. J Acquir Immune Defic Syndr 45: 251-252.
23. Petroni A, Deluchi G, Pryluka D, Rotryng F, Bortolozzi R, Lopardo G, Bouzas MB, Zapiola I, Garone D, Rodriguez C, Chiocconi E, Lázaro ME, Murano F, Maranzana A, Oliva SM, Aparicio M, Beltrán M, Benetucci JA 2006. Update on primary HIV-1 resistance in Argentina: emergence of mutations conferring high-level resistance to nonnucleoside reverse transcriptase inhibitors in drug-naive patients. J Acquir Immune Defic Syndr 42: 506-510.
24. Quan Y, Brenner, BG, Dascal A, Wainberg MA 2008. Highly diversified multiply drug-resistant HIV-1 quasispecies in PBMCs. Retrovirology 5:43.
25. Rios M, Fernandez J, Jaramillo P, Paredes V, Sanchez JL, Laguna-Torres VA, Carr JK, Ramirez E 2005. Molecular epidemiology of HIV type 1 in Chile: differential geographic and transmission route distribution of B and F subtypes. AIDS Res Hum Retroviruses 21: 835-840.
26. Rodrigues R, Custodio RM, Bueno SM, Eira M, Ferreira JL, Jamal L, Duarte AJ, Brigido LF 2005. Prevalence of ARV resistance mutations and impact of genotyping test in HIV patients with advance disease in São Paulo, Brazil, J Clin Virol 32: 336-337.
27. Rodrigues R, Scherer LC, Oliveira CM, Franco HM, Sperhacke RD, Ferreira JL, Castro SM, Stella IM, Brigido LF 2006. Low prevalence of primary antiretroviral resistance mutations and predominance of HIV-1 clade C at polymerase gene in newly diagnosed individuals from south Brazil. Virus Research 16: 201-207.
28. Ryan CE, Janet G, Crowe SM, Reeder JC, Oelrichs RB 2007. The heterosexual HIV type 1 epidemic in Papua, New Guinea is dominated by subtype C. AIDS Res Hum Retroviruses 23: 941-944.
29. Sá-Ferreira JA, Brindeiro PA, Chequer-Fernandez S, Tanuri A, Morgado MG 2007. Human immunodeficiency virus-1 subtypes and antiretroviral drug resistance profiles among drug-naïve Brazilian blood donors. Transfusion 47: 97-102.
30. Salminen MO, Carr JK, Burke DS, McCutchan FE 1995. Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses 11: 1423-1425.
31. Santos AF, Sousa TM, Soares EA, Sanabani S, Martinez AM, Sprinz E, Silveira J, Sabino EC, Tanuri A, Soares MA 2006. Characterization of a new circulating recombinant form comprising HIV-1 subtypes C and B in Southern Brazil. AIDS 20: 2011-2019.
32. Sarker MS, Rahmana M, Yirrell D, Campbell E, Rahmane AS, Islamd LN, AzimaT 2008. Molecular evidence for polyphyletic origin of human immunodeficiency virus type 1 subtype C in Bangladesh. Virus Research 135: 89-94.
33. Shafer RW, Rhee SY, Pillay D, Miller V, Sandstrom P, Schapiro JM, Kuritzkes DR, Bennett D 2007. HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance. AIDS 21: 215-223.
34. Shepherd JC, Jacobson LP, Qiao W, Jamieson BD, Phair JP, Piazza P, Quinn TC, Margolick JB 2008. Emergence and persistence of CXCR4-Tropic HIV-1 in a population of men from the Multicenter AIDS Cohort Study. J Infect Dis 198: 1104-1112.
35. Soares EA, Martinez AM, Souza TM, Santos AF, Da Hora V, Silveira J, Bastos FI, Tanuri A, Soares MA 2005. HIV-1 subtype C dissemination in Southern Brazil. AIDS 19 S: S81-86.
36. Stebbing J, Moyle G 2003. The clades of HIV: their origins and clinical significance. AIDS Rev 5: 205-213.
37. Stefani MM, Pereira GA, Lins JA, Alcantara KC, Silveira AA, Viegas AA, Maya NC, Mussi AH 2007. Molecular screening shows extensive HIV-1 genetic diversity in Central West Brazil. J Clin Virol 39: 205-209.
38. Stuyver L, Wyseur A, Rombout A, Louwagie J, Scarcez T, Verhofstede C, Rimland D, Schinazi RF, Rossau R 1997. Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene. Antimicrob Agents Chemother 41: 284-291.
39. Sucupira MCA, Caseiro MM, Alves K, Tescarollo G, Janini LM, Sabino EC, Castelo A, Shafer K, Diaz RS 2007. High levels of primary antiretroviral resistance genotypic mutations and B/F recombinants in Santos, Brazil. Aids Patient Care STDS 21: 116-128.
40. Swofford D 1999. PAUP 4.0: Phylogenetic analysis with parsimony (and other methods), version 4.0b2a. Sunderland, Mass: Sinauer Associates Inc.
41. Tebit DM, Nankya I, Arts EJ, Gao Y 2007. HIV diversity, recombination and disease progression: how does fitness "fit" into the puzzle? AIDS Reviews 9: 75-87.
42. Teixeira SL, Bastos FI, Telles PR, Hacker MA, Brigido LF, de F Oliveira CA, Bongertz V, Morgado MG 2004. HIV-1 infection among injection and ex-injection drug users from Rio de Janeiro, Brazil: prevalence, estimated incidence and genetic diversity. J Clin Virol 31: 221-226.
43. Thompson J, Higgins D, Gibson T 1994. Clustal W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight choice. Nucleic Acid Res 22: 4673-4680.
44. Tovanabutra S, Beyrer C, Sakkhachornphop S, Razak MH, Ramos GI, Yongchak T, Rungruengthanakit K, Saokhieo P, Tejafong K, Kim. B, de Souza M, Robb MI, Birx DI, Jittiwutikarn J, Suriyanon V, Celentano DD, Mccutcha F 2004. The changing molecular epidemiology of HIV type 1 among Northern Thai drug users, 1999 to 2002. Aids Res Hum Retroviruses 20: 465-475.
45. Tovanabutra S, Polonis V, De Souza M, Trichavaroj R, Chanbancherd P, Kim B, Sanders-Buell E, Nitayaphan S, Brown A, Robb MR, Birx DL, McCutchan FE, Carr JK 2001. First CRF01-AE/B recombinant of HIV-1 is found in Thailand. AIDS 15: 1063-1065.
46. Van-Harmelen J, Wood R, Lambrick M, Rybicki EP, Williamson AL, Williamson C 1997. An association between HIV-1 subtypes and mode of transmission in Cape Town, south Africa. AIDS 11: 81-87.
47. WHO-UNAIDS 2002. Guidelines for standard hiv isolation and characterization procedures, 2nd ed., Health and Development Ed, Geneva, 140 pp.
48. Yang C, Li M, Newman RD, Shi YP, Ayisi J, van Eijk AM, Otieno J, Misore AO, Steketee RW, Nahlen BL, Lal RB 2003. Genetic diversity of HIV-1 in Western Kenya: subtype-specific differences in mother-to-child transmission. AIDS 17: 1667-1674.